Medexus Pharmaceuticals Inc. (MDP.TO)

CAD 2.76

(-1.43%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 155.73 Million 161.32 Million 139.22 Million 148.51 Million 122.81 Million 85 Million
Total Current Assets 72.49 Million 72.96 Million 49.11 Million 58.57 Million 40.04 Million 35.05 Million
Cash And Short Term Investments 5.25 Million 13.06 Million 10.01 Million 18.7 Million 5.23 Million 21.87 Million
Cash and Cash Equivalents 5.25 Million 13.06 Million 10.01 Million 18.7 Million 5.23 Million 21.87 Million
Short Term Investments - - - - - -
Net Receivables 24.03 Million 22.38 Million 14.4 Million 18.82 Million 14.96 Million 7.44 Million
Inventory 30.77 Million 22.84 Million 21.35 Million 14.66 Million 14.08 Million 4.23 Million
Other Current Assets 2.3 Million 2.29 Million 1.28 Million 1.66 Million 1.41 Million 1.5 Million
Total Non-Current Assets 83.23 Million 88.36 Million 90.11 Million 89.94 Million 82.76 Million 49.95 Million
Net PPE 778 Thousand 899 Thousand 1.22 Million 795 Thousand 1.09 Million 649.42 Thousand
Good Will And Intangible Assets 74.41 Million 80.65 Million 87.25 Million 87.01 Million 79.54 Million 48.78 Million
Good Will 10.27 Million 10.28 Million 10.68 Million 10.65 Million 10.06 Million 6.99 Million
Intangible Assets 64.14 Million 70.37 Million 76.56 Million 76.36 Million 69.48 Million 41.78 Million
Long-Term Investments - -9.19 Million - - - -1.16 Million
Tax Assets 8.04 Million 6.8 Million - - - 1.16 Million
Other Non Current Assets - 9.19 Million 1.64 Million 2.13 Million 2.11 Million 520.42 Thousand
Other Assets - - - - 1.00 1.00
Total Liabilities 125.41 Million 138.88 Million 121.43 Million 130.49 Million 98.53 Million 57.13 Million
Total Current Liabilities 66.22 Million 83.49 Million 48.1 Million 39.93 Million 34.17 Million 10.59 Million
Account Payables 7.75 Million 10.15 Million 12.04 Million 14.85 Million 8.9 Million 3 Million
Tax Payables 1.31 Million 1.18 Million 27 Thousand 514 Thousand 680.43 Thousand 473.11 Thousand
Short Term Debt 15.74 Million 42.7 Million 15.04 Million 10.56 Million 10.19 Million -
Deferred Revenue 40.03 Million 27.93 Million 18.38 Million - 1.00 -
Other Current Liabilities 2.7 Million 2.7 Million 2.63 Million 14.51 Million 15.07 Million 7.58 Million
Total Non Current Liabilities 59.18 Million 55.38 Million 73.32 Million 90.55 Million 64.35 Million 46.54 Million
Long-Term Debt 34.15 Million 27.37 Million 39.81 Million 34.3 Million 28.61 Million 16.87 Million
Deferred Revenue Non Current - - - - 1.00 -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 25.02 Million 28 Million 31.98 Million 53.61 Million 29.26 Million 24.07 Million
Other Liabilities - - - - 1.00 1.00
Total Equity 30.32 Million 22.44 Million 17.79 Million 18.01 Million 24.28 Million 27.87 Million
Stock Holders Equity 30.32 Million 22.44 Million 17.79 Million 18.01 Million 24.28 Million 27.87 Million
Common Stock 76.39 Million 69.01 Million 68.68 Million 66.68 Million 42.18 Million 46.39 Million
Retained Earnings -64.24 Million -64.02 Million -65.24 Million -62.37 Million -28.04 Million -25.26 Million
Accumulated other comprehensive income 6.17 Million 6.15 Million 3.97 Million 4.2 Million 3.5 Million 1.05 Million
Common Stock Equity 30.32 Million 22.44 Million 17.79 Million 18.01 Million 24.28 Million 27.87 Million
Capital Lease Obligation 479.05 Thousand 808.2 Thousand 978.91 Thousand 266.44 Thousand 785.19 Thousand -
Total Investments - -9.19 Million - - - -1.16 Million
Total Debt 49.89 Million 70.08 Million 54.86 Million 44.87 Million 38.81 Million 16.87 Million
Net Debt 44.64 Million 57.01 Million 44.84 Million 26.16 Million 33.57 Million -5 Million

Balance Sheet Charts